REAL-WORLD TREATMENT BURDEN ASSOCIATED WITH PARENTERAL ON-DEMAND THERAPIES FOR HEREDITARY ANGIOEDEMA

被引:0
|
作者
Tachdjian, R.
Savic, S.
Fridman, M.
Frade, J.
Audhya, P.
Fasehun, M.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P003
引用
收藏
页码:S15 / S16
页数:2
相关论文
共 50 条
  • [21] Fresh frozen plasma for on-demand hereditary angioedema treatment in South Africa and Iran
    Wentzel, Nicole
    Panieri, Angelica
    Ayazi, Maryam
    Ntshalintshali, Sipho Duncan
    Pourpak, Zahra
    Hawarden, Di
    Potter, Paul
    Levin, Michael E.
    Fazlollahi, Mohammad Reza
    Peter, Jonathan
    WORLD ALLERGY ORGANIZATION JOURNAL, 2019, 12 (09):
  • [22] COSTS AND EFFECTS OF ON-DEMAND TREATMENT OF HEREDITARY ANGIOEDEMA: A PROSPECTIVE COHORT STUDY IN ITALY
    Federici, C.
    Perego, F.
    Borsoi, L.
    Crosta, V
    Zanichelli, A.
    Gidaro, A.
    Tarricone, R.
    Cicardi, M.
    VALUE IN HEALTH, 2018, 21 : S451 - S451
  • [23] Comparative Economics of On-Demand Treatment Options Approved in the United Kingdom for Hereditary Angioedema
    Panahloo, Zoya
    Machnig, Thomas
    Zbrozek, Art
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB33 - AB33
  • [24] Reporting of Adverse Drug Reactions with Parenteral Drugs for the On-Demand Treatment of Hereditary Angioedema Attacks - Analysis of the FAERS Database 2009 to 2022
    Tachdjian, Raffi
    Savic, Sinisa
    Savic, Sinisa
    Fridman, Moshe
    Frade, Joao
    Audhya, Paul
    Fasehun, Marie
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB144 - AB144
  • [25] Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks
    Tyson, Christopher
    Relan, Anurag
    Adams, Philippe
    Haynes, Angela
    Magar, Raf
    ALLERGY AND ASTHMA PROCEEDINGS, 2019, 40 (05) : 359 - 359
  • [26] Are hereditary angioedema patients satisfied with on-demand therapy with icatibant?
    Beyaz, Sengul
    Demir, Semra
    Oztop, Nida
    Colakoglu, Bahauddin
    Buyukozturk, Suna
    Gelincik, Asli
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 357 - 357
  • [27] Treatment of hereditary angioedema with icatibant: Efficacy in clinical trials versus effectiveness in the real-world setting
    Maurer, Marcus
    Longhurst, Hilary J.
    Fabien, Vincent
    Li, H. Henry
    Lumry, William R.
    ALLERGY AND ASTHMA PROCEEDINGS, 2014, 35 (05) : 377 - 381
  • [28] Lanadelumab for the prevention of hereditary angioedema attacks: A real-world UK audit
    Dorr, Anthony D.
    Chopra, Charu
    Coulter, Tanya I.
    Dempster, John
    Dziadzio, Magdalena
    El-Shanawany, Tariq
    Garcez, Tomaz
    Gompels, Mark
    Herriot, Richard
    Jain, Rashmi
    Levi, Marcel
    Lorenzo, Lorena
    Makki, Inas
    Mapazire, Elizabeth
    Murng, Sai H. K.
    Noorani, Sadia
    Savic, Sinisa
    Steele, Cathal L.
    Symons, Christine
    Tarzi, Michael
    Yong, Patrick F. K.
    Kiani-Alikhan, Sorena
    ALLERGY, 2023, 78 (05) : 1369 - 1371
  • [29] Real-World Outcomes in Patients with Hereditary Angioedema (HAE) Treated with Berotralstat
    Anderson, John
    Desai, Bhavisha
    Tilley, Alex
    Johnston, Douglas
    Wasilewski, Stephanie
    Banerji, Aleena
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB135 - AB135
  • [30] EARLY ICATIBANT TREATMENT IS ASSOCIATED WITH FASTER RESOLUTION OF HEREDITARY ANGIOEDEMA ATTACKS: REAL-WORLD DATA FROM THE ICATIBANT OUTCOME SURVEY
    Longhurst, H.
    Caballero, T.
    Zanichelli, A.
    Aberer, W.
    Fabien, V.
    Bouillet, L.
    Maurer, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A47 - A48